These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 32835666)
61. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality. Li G; Saguner AM; An J; Ning Y; Day JD; Ding L; Waintraub X; Wang J Cardiol J; 2020; 27(5):616-624. PubMed ID: 32789839 [TBL] [Abstract][Full Text] [Related]
62. Pathological Interplay and Clinical Complications between COVID-19 and Cardiovascular Diseases: An Overview in 2023. Zhou S; Zhang A; Liao H; Liu Z; Yang F Cardiology; 2024; 149(1):60-70. PubMed ID: 37586358 [TBL] [Abstract][Full Text] [Related]
63. Sex differences in the cardiac stress response following SARS-CoV-2 infection of ferrets. Rouhana S; Jacyniak K; Francis ME; Falzarano D; Kelvin AA; Pyle WG Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1153-H1167. PubMed ID: 37737732 [TBL] [Abstract][Full Text] [Related]
65. COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network. Kario K; Morisawa Y; Sukonthasarn A; Turana Y; Chia YC; Park S; Wang TD; Chen CH; Tay JC; Li Y; Wang JG; J Clin Hypertens (Greenwich); 2020 Jul; 22(7):1109-1119. PubMed ID: 32643874 [TBL] [Abstract][Full Text] [Related]
66. Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility. Daniel G; Paola AR; Nancy G; Fernando SO; Beatriz A; Zulema R; Julieth A; Claudia C; Adriana R Infect Genet Evol; 2022 Oct; 104():105357. PubMed ID: 36038007 [TBL] [Abstract][Full Text] [Related]
67. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2. Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084 [TBL] [Abstract][Full Text] [Related]
68. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications. Higashikuni Y; Liu W; Obana T; Sata M Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769508 [TBL] [Abstract][Full Text] [Related]
69. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients. Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010 [TBL] [Abstract][Full Text] [Related]
70. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis. Seeherman S; Suzuki YJ Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193 [TBL] [Abstract][Full Text] [Related]
72. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors. Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736 [TBL] [Abstract][Full Text] [Related]
73. Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis. Cheng MP; Cau A; Lee TC; Brodie D; Slutsky A; Marshall J; Murthy S; Lee T; Singer J; Demir KK; Boyd J; Ohm H; Maslove D; Goffi A; Bogoch II; Sweet DD; Walley KR; Russell JA; Crit Care Med; 2021 Sep; 49(9):1558-1566. PubMed ID: 33870918 [TBL] [Abstract][Full Text] [Related]
74. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587 [TBL] [Abstract][Full Text] [Related]
75. The cardiovascular aspect of COVID-19. Adu-Amankwaah J; Mprah R; Adekunle AO; Ndzie Noah ML; Adzika GK; Machuki JO; Sun H Ann Med; 2021 Dec; 53(1):227-236. PubMed ID: 33345626 [TBL] [Abstract][Full Text] [Related]
76. Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19. Salah HM; Mehta JL J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):114-118. PubMed ID: 33078623 [TBL] [Abstract][Full Text] [Related]
77. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Bernard I; Limonta D; Mahal LK; Hobman TC Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371 [TBL] [Abstract][Full Text] [Related]
78. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection. Robinson FA; Mihealsick RP; Wagener BM; Hanna P; Poston MD; Efimov IR; Shivkumar K; Hoover DB Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1059-H1068. PubMed ID: 33036546 [TBL] [Abstract][Full Text] [Related]
79. Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome. Foresta C; Rocca MS; Di Nisio A J Endocrinol Invest; 2021 May; 44(5):951-956. PubMed ID: 32936429 [TBL] [Abstract][Full Text] [Related]